Warning: count(): Parameter must be an array or an object that implements Countable in /home/logicben/public_html/drugtrialsformoney.com/wp-content/plugins/redux-framework/redux-core/inc/classes/class-redux-output.php on line 391

A Study of Multiple Immunotherapy-Based Treatment Combinations in Patients With Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction Cancer (G/GEJ) (Morpheus-Gastric Cancer)

A Study of Multiple Immunotherapy-Based Treatment Combinations in Patients With Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction Cancer (G/GEJ) (Morpheus-Gastric Cancer)
Condition:   Gastric Adenocarcinoma or Gastroesophageal Junction Adenocarcinoma
Interventions:   Drug: 5-Fluorouracil (5-FU);   Drug: Leucovorin;   Drug: Oxaliplatin;   Biological: Atezolizumab;   Drug: Cobimetinib;   Biological: Ramucirumab;   Drug: Paclitaxel;   Biological: PEGylated recombinant human hyaluronidase (PEGPH20);   Drug: BL-8040;   Drug: Linagliptin
Sponsors:   Hoffmann-La Roche;   Halozyme Therapeutics;   BioLineRx, Ltd.
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

October 30, 2019 / by / in
Comments